Safety Evaluation of Amphiphilic Three-Armed Star-Shaped Copolymer Micelles

Branco, 2009, Self-assembling materials for therapeutic delivery, Acta Biomater, 5, 817, 10.1016/j.actbio.2008.09.018 Venugopal, 2005, Applications of polymer nanofibers in biomedicine and biotechnology, Appl Biochem Biotechonol, 125, 147, 10.1385/ABAB:125:3:147 Olenius, 1998, The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds, Aesthetic Plast Surg, 322, 97, 10.1007/s002669900172 Shenoy, 2005, Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer, Int J Pharm, 293, 261, 10.1016/j.ijpharm.2004.12.010 Deshpande, 2007, Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer, Int J Cancer, 121, 1830, 10.1002/ijc.22886 Gou, 2008, A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel, Int J Pharm, 359, 228, 10.1016/j.ijpharm.2008.03.023 Forrest, 2006, In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles, J Control Release, 110, 370, 10.1016/j.jconrel.2005.10.008 Forrest, 2008, Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly (epsilon-caprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity, Pharm Res, 25, 194, 10.1007/s11095-007-9451-9 Molavi, 2008, Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors, Int J Pharm, 347, 118, 10.1016/j.ijpharm.2007.06.032 Du, 2005, pH-sensitive vesicles based on a biocompatible zwitterionic diblock copolymer, J Am Chem Soc, 127, 17982, 10.1021/ja056514l Opanasopit, 2005, Influence of serum and albumins from different species on stability of camptothecin-loaded micelles, J Control Release, 104, 313, 10.1016/j.jconrel.2005.02.014 Xiong, 2008, Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats, J Control Release, 129, 33, 10.1016/j.jconrel.2008.03.015 Cheng, 2007, Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery, Biomaterials, 28, 869, 10.1016/j.biomaterials.2006.09.047 Meier, 2005, PEO-b-PCL block copolymers: Synthesis, detailed characterization, and selected micellar drug encapsulation behavior, Macromol Rapid Commun, 26, 1918, 10.1002/marc.200500591 Stevenson-Abouelnasr, 2007, Further investigation of the mechanism of doxorubicin release from P105 micelles using kinetic models, Colloids Surf B Biointerfaces, 55, 59, 10.1016/j.colsurfb.2006.11.006 Hyun, 2008, Polymeric nano-micelles using poly(ethylene glycol) and poly(trimethylene carbonate) diblock copolymers as a drug carrier, Colloids Surf A Physicochem Eng Aspects, 313–314, 131, 10.1016/j.colsurfa.2007.05.078 Langer, 2003, Advances in biomaterials, drug delivery, and bionanotechnology, AIChE J, 49, 2990, 10.1002/aic.690491202 Sung, 2004, The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis, Biomaterials, 25, 5735, 10.1016/j.biomaterials.2004.01.066 Jeong, 2004, In vivo biocompatibility and degradation behavior of elastic poly(L-lactide-co-ε-caprolactone) scaffolds, Biomaterials, 25, 5939, 10.1016/j.biomaterials.2004.01.057 Uel, 2009, Accelerated degradation behaviour of poly(3-caprolactone) via melt blending with poly(aspartic acid-co-lactide) (PAL), Polym Degradation Stability, 94, 213, 10.1016/j.polymdegradstab.2008.11.001 Pignatello, 2009, Poly(3-hydroxybutyratε-co-ε- caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-ε-caprolactone) terpolymers as novel materials for colloidal drug delivery systems, Eur J Pharm Sci, 37, 451, 10.1016/j.ejps.2009.03.017 Qiu, 2006, Polymer architecture and drug delivery, Pharm Res, 23, 1, 10.1007/s11095-005-9046-2 Ahmed, 2004, Self-porating polymersomes of PEG-PLA and PEG-PCL: Hydrolysis-triggered controlled released, J Control Release, 96, 37, 10.1016/j.jconrel.2003.12.021 Cho, 2009, Synthesis and characterization of fluorescein isothiocyanate (FITC)-labeled PEO-PCL-PEO triblock copolymers for topical delivery, Polymer, 50, 2357, 10.1016/j.polymer.2009.03.032 Torchilin, 2007, Micellar nanocarriers: Pharmaceutical perspectives, Pharm Res, 24, 1, 10.1007/s11095-006-9132-0 Pawar, 2004, Protein and peptide parenteral controlled delivery, Expert Opin Biol Ther, 4, 1203, 10.1517/14712598.4.8.1203 Shi, 2005, Current advances in sustained-release systems for parenteral drug delivery, Expert Opin Drug Deliv, 2, 1039, 10.1517/17425247.2.6.1039 Lee, 2007, Polymeric protein delivery systems, Prog Polym Sci, 32, 669, 10.1016/j.progpolymsci.2007.04.001 Wright, 2002, Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences, Adv Drug Deliv Rev, 54, 1057, 10.1016/S0169-409X(02)00059-5 Qiu, 2007, Polymeric micelles as nanocarriers for drug delivery, Expert Opin Ther Patents, 17, 819, 10.1517/13543776.17.7.819 Davis, 2004, Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers, Curr Med Chem, 11, 179, 10.2174/0929867043456179 Wei, 2009, Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(-ethylene glycol)-poly(s-caprolactone) copolymer, Int J Pharm, 369, 170, 10.1016/j.ijpharm.2008.10.027 Chen, 2007, Acute oral toxicity evaluation of biodegradable and pH-sensitive hydrogel based on polycaprolactone, poly(ethylene glycol) and methyl acrylic acid (MAA), J Biomed Mater Res A, 84, 589, 10.1002/jbm.b.30832